Indeed, the genetic depletion of α-SMA-expressing cells in a genetically engineered pancreatic cancer mouse model increased tumor aggressiveness (with undifferentiated and highly metastatic tumor cells), ultimately reducing animal survival [278]. This evidence concerns the gene ACTA1 and neoplasm.